Pearl Expands Leadership Team to Advance Dental AI Mission

The pioneering dental AI company adds world-class talent to leadership bench with appointment of Ben Plomion as Chief Operating Officer and Dr. Mike Barniv as VP Clinical Affairs
Pearl, the global leader in dental AI solutions, today announced the appointment of Ben Plomion to Chief Operating Officer and Mike Barniv, DDS to Vice President of Clinical Affairs. Plomion and Barniv will help drive the company’s next phase of growth and innovation while further strengthening Pearl’s leadership team.
As Pearl’s new COO, Plomion will oversee cross-departmental operations with a comprehensive focus on scaling the company’s growth. Prior to joining Pearl, Plomion served as the Chief Marketing Officer at Dibbs, a tokenization-as-service platform, and Chief Growth and Marketing Officer at GumGum, an artificial intelligence advertising company. With over two decades of experience driving successful commercialization efforts in the field of AI, Plomion will play a key role in the advancement of Pearl’s development and commercial operations.
Dr. Barniv joins Pearl as the company’s Vice President of Clinical Affairs after spending 20 years as a full-time, private practice dentist. Most recently, he served as Vice President at Delta Dental of Idaho, overseeing claims, customer service, utilization management and AI implementation. As a former assistant professor at the University of the Pacific School of Dentistry in San Francisco, CA and the director of their AEGD residency clinic for over four years, Barniv will apply his extensive multidisciplinary dental experience towards advancing the company’s commercial, clinical, and institutional impact.
“Ben and Mike each bring uniquely relevant and valuable experience to Pearl’s growing leadership team, and we’re privileged to welcome their support as we expand our capabilities and reach across the global dental market,” said Ophir Tanz, founder and CEO of Pearl. “Ben’s world-class growth and organizational leadership and Mike’s extraordinary clinical and commercial versatility prime Pearl to further expand its efforts to redefine the AI-powered future of dentistry.”